T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
LeMaitre Vascular
LMAT
$1.88B
| $72.5M | 0.01% |
755,142
+460,148
| +156% | +$47.2M |
|
777
ResMed
RMD
$32B
| $72.4M | 0.01% |
371,658
-100,961
| -21% | -$20.9M |
|
778
Knowles
KN
$3.19B
| $72.3M | 0.01% |
1,742,006
+1,642,915
| +1,658% | +$57M |
|
|
EA
779
DELISTED
Electronic Arts
EA
| $72M | 0.01% |
350,933
+5,564
| +2% | +$1.13M |
|
780
McCormick & Company Non-Voting
MKC
$13B
| $71.9M | 0.01% |
1,425,857
+517,393
| +57% | +$25.4M |
|
781
Oric Pharmaceuticals
ORIC
$1.4B
| $71.7M | 0.01% |
6,617,554
+1,229,771
| +23% | +$11.2M |
|
782
GE HealthCare
GEHC
$30B
| $71.3M | 0.01% |
1,113,956
+459,555
| +70% | +$30.2M |
|
783
Apple Hospitality REIT
APLE
$3.87B
| $71.1M | 0.01% |
4,226,690
-407,466
| -9% | -$5.83M |
|
784
Cohu
COHU
$3.14B
| $70.9M | 0.01% |
959,839
+904,341
| +1,630% | +$45.2M |
|
|
CDNL
785
Cardinal Infrastructure Group
CDNL
$568M
| $70.9M | 0.01% |
752,941
+743,877
| +8,207% | +$42.8M |
|
786
Immunovant
IMVT
$6.91B
| $70.5M | 0.01% |
1,829,210
+1,489,603
| +439% | +$45.4M |
|
787
Devon Energy
DVN
$51.7B
| $70.4M | 0.01% |
1,702,866
+797,338
| +88% | +$37M |
|
788
Boston Properties
BXP
$9.9B
| $70.3M | 0.01% |
1,060,150
+250,063
| +31% | +$15M |
|
789
Kulicke & Soffa
KLIC
$4.78B
| $70.2M | 0.01% |
524,975
+314,708
| +150% | +$30.8M |
|
790
SiriusPoint
SPNT
$2.92B
| $70M | 0.01% |
2,916,654
+2,167,356
| +289% | +$49.7M |
|
791
Cullinan Oncology
CGEM
$969M
| $69.7M | 0.01% |
3,825,950
+1,796,231
| +88% | +$26.7M |
|
792
Urban Outfitters
URBN
$6.52B
| $69.6M | 0.01% |
982,065
+621,875
| +173% | +$44.3M |
|
793
Arrowhead Research
ARWR
$9.3B
| $69.6M | 0.01% |
853,360
-190,372
| -18% | -$14.1M |
|
794
Construction Partners
ROAD
$5.2B
| $69.3M | 0.01% |
583,671
-201,659
| -26% | -$23.9M |
|
795
Murphy USA
MUSA
$9.55B
| $69.1M | 0.01% |
128,294
+111,640
| +670% | +$60.6M |
|
796
Sysco
SYY
$37.5B
| $68.9M | 0.01% |
824,716
+16,813
| +2% | +$1.27M |
|
797
Alcoa
AA
$11.2B
| $68.9M | 0.01% |
1,321,021
-62,613
| -5% | -$4.19M |
|
798
OSI Systems
OSIS
$3.09B
| $68.8M | 0.01% |
314,717
+55,172
| +21% | +$13.5M |
|
799
Okta
OKTA
$35.2B
| $68.2M | 0.01% |
499,640
+146,343
| +41% | +$13.8M |
|
800
NewMarket
NEU
$8.39B
| $68M | 0.01% |
85,978
+15,693
| +22% | +$11.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.